Back to School: How biopharma can reboot drug development. Access exclusive analysis here

NTC-121: Began Phase I/II trial

Neurotech S.A., Evry, France
Product: NTC-121
Business:

Read the full 74 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE